Sinopharm
1099.HK
#2120
Rank
โ‚น631.19 B
Marketcap
โ‚น202.26
Share price
0.00%
Change (1 day)
-7.10%
Change (1 year)
The Sinopharm Group is a Chinese pharmaceutical company that researches, develops, produces, sells and markets pharmaceuticals and other health products.

Market capitalization of Sinopharm (1099.HK)

Market cap: โ‚น631.19 Billion

As of March 2025 Sinopharm has a market cap of โ‚น631.19 Billion. This makes Sinopharm the world's 2120th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Sinopharm from 2009 to 2025

End of year Market Cap

Year Marketcap Change
2025โ‚น631.19 B-16.24%
2024โ‚น753.60 B10.77%
2023โ‚น680.33 B3.48%
2022โ‚น657.42 B30.13%
2021โ‚น505.20 B-4.25%
2020โ‚น527.61 B-31.84%
2019โ‚น774.11 B-11.32%
2018โ‚น872.97 B14.27%
2017โ‚น763.97 B-1.38%
2016โ‚น774.69 B4.99%
2015โ‚น737.85 B18.89%
2014โ‚น620.64 B36.32%
2013โ‚น455.27 B10.62%
2012โ‚น411.56 B34.88%
2011โ‚น305.13 B-13.65%
2010โ‚น353.36 B-5.35%
2009โ‚น373.34 B

End of Day market cap according to different sources

On Mar 25th, 2025 the market cap of Sinopharm was reported to be:

โ‚น645.63 Billion
by Yahoo Finance info icon info icon
โ‚น645.63 Billion
by CompaniesMarketCap info icon info icon